Task: Answer the multiple-choice question.
Question: Which drug exhibits a 10.382% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: CC(=O)NCCc1nc2cc(NS(=O)(=O)c3ccc(Cl)cc3)ccc2n1C
b: CCOC(=O)C1CCCN(CC(O)COC(c2ccccc2)c2ccccc2)C1
c: CCc1ccc(NC(=O)Nc2cccs2)cc1
Answer: a. CC(=O)NCCc1nc2cc(NS(=O)(=O)c3ccc(Cl)cc3)ccc2n1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)NCCc1nc2cc(NS(=O)(=O)c3ccc(Cl)cc3)ccc2n1C
CC(=O)NCCc1nc2cc(NS(=O)(=O)c3ccc(Cl)cc3)ccc2n1C
N-[2-[5-[(4-chlorophenyl)sulfonylamino]-1-methylbenzimidazol-2-yl]ethyl]acetamide